RhumbLine Advisers’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
|
|||||
|
2025
Q1 | $2.23M | Buy |
|
|||||
|
2024
Q4 | $2.11M | Buy |
|
|||||
|
2024
Q3 | $1.66M | Sell |
|
|||||
|
2024
Q2 | $1.03M | Buy |
|
|||||
|
2024
Q1 | $825K | Sell |
|
|||||
|
2023
Q4 | $973K | Sell |
|
|||||
|
2023
Q3 | $1.01M | Sell |
|
|||||
|
2023
Q2 | $1.74M | Buy |
|
|||||
|
2023
Q1 | $2.2M | Buy |
|
|||||
|
2022
Q4 | $2.05M | Buy |
|
|||||
|
2022
Q3 | $2.33M | Buy |
|
|||||
|
2022
Q2 | $2.12M | Sell |
|
|||||
|
2022
Q1 | $2.34M | Sell |
|
|||||
|
2021
Q4 | $3.04M | Buy |
|
|||||
|
2021
Q3 | $2.36M | Buy |
|
|||||
|
2021
Q2 | $1.38M | Buy |
|
|||||
|
2021
Q1 | $1.72M | Sell |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $1.23M | Sell |
|
|||||
|
2020
Q2 | $1.46M | Sell |
|
|||||
|
2020
Q1 | $1.16M | Sell |
|
|||||
|
2019
Q4 | $1.16M | Buy |
|
|||||
|
2019
Q3 | $856K | Buy |
|
|||||
|
2019
Q2 | $1.46M | Buy |
|
|||||
|
2019
Q1 | $1.26M | Buy |
|
|||||
|
2018
Q4 | $1.25M | Buy |
|
|||||
|
2018
Q3 | $1.05M | Sell |
|
|||||
|
2018
Q2 | $1.06M | Sell |
|
|||||
|
2018
Q1 | $884K | Sell |
|
|||||
|
2017
Q4 | $857K | Sell |
|
|||||
|
2017
Q3 | $1.2M | Buy |
|
|||||
|
2017
Q2 | $920K | Buy |
|
|||||
|
2017
Q1 | $839K | Buy |
|
|||||
|
2016
Q4 | $818K | Sell |
|
|||||
|
2016
Q3 | $988K | Sell |
|
|||||
|
2016
Q2 | $788K | Buy |
|
|||||
|
2016
Q1 | $474K | Sell |
|
|||||
|
2015
Q4 | $670K | Buy |
|
|||||
|
2015
Q3 | $640K | Buy |
|
|||||
|
2015
Q2 | $1.02M | Buy |
|
|||||
|
2015
Q1 | $495K | Buy |
|
|||||
|
2014
Q4 | $216K | Buy |
|
|||||
|
2014
Q3 | $155K | Hold |
|
|||||
|
2014
Q2 | $201K | Buy |
|